Effect of MK0524A on Cholesterol Levels (0524A-048)

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of the study is to assess the effects of MK0524A in reducing cholesterol levels in an Asian population.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Niacin; Niacinamide; Nicotinic Acids

Criteria

Inclusion Criteria:

• Patient is male or female between 18 and 70 years of age

• Females of reproductive potential must agree to take acceptable contraceptive precautions for the duration of the study

Exclusion Criteria:

• Patient has a history of not being able to take niacin or niacin-containing products

• Patient consumes more than 2 alcoholic beverages per day

• Patient has poorly controlled Type 1 or Type 2 diabetes mellitus

• Patient engages in vigorous exercise or an aggressive diet regimen